Heather Armstrong Selected Research

conantokin R

9/2002

Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heather Armstrong Research Topics

Disease

2	Ulcerative Colitis 06/2022 - 01/2019
2	Infections 06/2022 - 01/2016
2	Neoplasms (Cancer) 02/2021 - 03/2018
2	Inflammation (Inflammations) 01/2020 - 03/2018
2	Urinary Tract Infections (Urinary Tract Infection) 01/2018 - 01/2016
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 06/2022
1	Fistula 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Crohn Disease (Crohn's Disease) 01/2019
1	Epilepsy (Aura) 09/2002

Drug/Important Bio-Agent (IBA)

1	VitaminsIBA 02/2021
1	Dietary Fiber FDA Link 01/2020
1	Immunoglobulin G (IgG)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2002
1	conantokin RIBA 09/2002

Therapy/Procedure

2	Therapeutics 06/2022 - 02/2021
2	Antibiotic Prophylaxis 01/2018 - 01/2016
1	Self-Testing 06/2022
1	Cesarean Section (Caesarean Section) 01/2020